/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

H

Henry Danahay

Enterprise Sciences (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

72

Papers

2.5K

Citations

26

h-index

38

i10-index

Henry Danahay is an academic researcher from Enterprise Sciences (United States). The author has contributed to research in topics: Cystic Fibrosis Research Advances & Asthma and respiratory diseases & Ion channel regulation and function. The author has an h-index of 26, co-authored 62 publications.

ORCID: 0009-0004-7180-752X

Research Topics

Cystic Fibrosis Research Advances Asthma and respiratory diseases Ion channel regulation and function Neonatal Respiratory Health Research Ion Transport and Channel Regulation

Papers by this author

works

Notch2 Is Required for Inflammatory Cytokine-Driven Goblet Cell Metaplasia in the Lung

2014 · Cell Reports · 253 citations

https://doi.org/10.1016/j.celrep.2014.12.017

Henry Danahay Angelica D. Pessotti Julie Coote Brooke E. E. Montgomery

ETD001: A novel inhaled ENaC blocker with an extended duration of action in vivo

2024 · Journal of Cystic Fibrosis · 5 citations

https://doi.org/10.1016/j.jcf.2024.06.002

Henry Danahay Clive McCarthy Thomas B Schofield Roy Fox

Optimisation of a novel series of ENaC inhibitors, leading to the selection of the long-acting inhaled clinical candidate ETD001, a potential new treatment for cystic fibrosis

2024 · European Journal of Medicinal Chemistry · 3 citations

https://doi.org/10.1016/j.ejmech.2024.117040

Henry Danahay Martin Gosling Roy Fox Sarah Lilley

Research topics

topics

Cystic Fibrosis Research Advances

Asthma and respiratory diseases

Ion channel regulation and function

Neonatal Respiratory Health Research

Ion Transport and Channel Regulation

Chat about Author

Papers

Chat

Click to start Chat